110944 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Metapneumovirus, e.g. avian pneumovirus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
PAN-PNEUMOVIRUS VACCINE COMPOSITIONS AND METHODS OF USE THEREOF
#2HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES
#3Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#4Virus causing respiratory tract illness in susceptible mammals
#5Virus causing respiratory tract illness in susceptible mammals
#6Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#7Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#8Virus causing respiratory tract illness in susceptible mammals
#9Virus causing respiratory tract illness in susceptible mammals
#10strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#11Virus causing respiratory tract illness in susceptible mammals
#12Virus causing respiratory tract illness in susceptible mammals
#13Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#14Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#15METAPNEUMOVIRUS STRAINS AND THEIR USE IN VACCINE FORMULATIONS AND AS VECTORS FOR EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS FOR PROPAGATING VIRUS
#16Metapneumovirus strains and their use in vaccine formulations and sequences
#17Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#18Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#19Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#20Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
#21Virus causing respiratory tract illness in susceptible mammals
#22Virus causing respiratory tract illness in susceptible mammals
#23Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus